METabolic EXplorer Bundle
Who Owns METabolic EXplorer Company?
Understanding METabolic EXplorer's ownership is key, especially after its receivership was converted to judicial liquidation in July 2024. This transition followed the sale of activities from its subsidiaries to Avril.
METabolic EXplorer, founded in 1999, aimed to revolutionize chemical compound production through bio-based processes, offering sustainable alternatives to petrochemical methods. The company focused on utilizing renewable resources to create environmentally friendly solutions for various industries.
Who holds the reins of METabolic EXplorer?
Founded in 1999, METabolic EXplorer focused on developing bio-based processes for chemical compounds, aiming for sustainable alternatives. The company's vision was to shift from fossil-based to bio-based chemistry, creating competitive and eco-friendly solutions for products like animal feed and cosmetics. This strategic direction is further illustrated by analyses such as the METabolic EXplorer BCG Matrix. Prior to its liquidation, METabolic EXplorer was publicly traded on Euronext Paris, with a market capitalization around €6.2 million as of July 20, 2025. The company employed 425 individuals as of June 2023, striving to advance consumer product manufacturing without oil dependency.
Who Founded METabolic EXplorer?
METabolic EXplorer was founded in 1999, with Benjamin Gonzalez serving as a key founder and holding the positions of Chairman and CEO. While specific initial equity distribution details are not publicly detailed, Gonzalez's vision was instrumental in establishing the company's focus on industrial biotechnology and bio-based chemical production. The company's early journey included its introduction to the Paris stock exchange in 2007, which opened its ownership to public shareholders at an initial price of 8.40 euros per share.
Founding Vision
Benjamin Gonzalez, a founder, established the company with a focus on industrial biotechnology. His leadership as Chairman and CEO guided the early strategic direction.
Company Inception
METabolic EXplorer was established in 1999. The core mission revolved around developing bio-based chemical production processes through fermentation.
Early Ownership Details
Precise initial equity splits are not readily available. Information on early backers or angel investors from the inception phase is also not specifically detailed.
Public Market Debut
The company made its debut on the Paris stock exchange in 2007. This marked a significant transition, opening METabolic EXplorer ownership to public investors.
Initial Public Offering (IPO)
The IPO price was set at 8.40 euros per share. This event was a key step in the company's ownership evolution and access to capital markets.
Strategic Focus
From its early days, the founding team's vision was clear: to pioneer bio-based chemical production. This strategy was central to the company's development and Revenue Streams & Business Model of METabolic EXplorer.
The early ownership structure of METabolic EXplorer was primarily shaped by its founder, Benjamin Gonzalez, and the strategic decision to go public. This transition in 2007 allowed for broader METabolic EXplorer ownership, moving from a potentially private, founder-led entity to a publicly traded company. While the specific breakdown of METabolic EXplorer shareholders at the time of the IPO is not detailed, the event itself signifies a shift towards a more diverse ownership base, including institutional investors and individual shareholders interested in the company's innovative approach to bio-based chemicals.
Key Aspects of Early Ownership
The initial phase of METabolic EXplorer's ownership was closely tied to its founding vision and leadership. The subsequent IPO significantly broadened the scope of who owns METabolic EXplorer.
- Founder: Benjamin Gonzalez, also serving as Chairman and CEO.
- Establishment Year: 1999, with a focus on industrial biotechnology.
- Public Offering: Introduction to the Paris stock exchange in 2007.
- IPO Price: 8.40 euros per share.
- Ownership Evolution: Transition from a potentially private entity to public ownership.
METabolic EXplorer SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has METabolic EXplorer’s Ownership Changed Over Time?
The ownership structure of METabolic EXplorer has undergone significant transformations, particularly following its IPO in 2007 and subsequent major transactions. These events have reshaped who owns METabolic EXplorer and its overall stakeholder landscape.
| Event | Date | Impact on Ownership |
|---|---|---|
| IPO on Euronext Paris | April 5, 2007 | Became a publicly held company, opening ownership to public investors. |
| Sale of Methionine Technology to Evonik | 2016 | Significant divestment of a core asset, impacting the company's operational focus and potentially its valuation. |
| Receivership Request | May 2024 | Initiated proceedings that led to a restructuring of its activities and ownership. |
| Avril Appointed Purchaser of Activities | July 2024 | Avril acquired key activities, leading to the judicial liquidation of METEX NØØVISTAGO and METabolic EXplorer. |
| Judicial Liquidation | July 16, 2024 | Resulted in the delisting of shares from Euronext with zero value for shareholders. |
The company's journey from a publicly traded entity to judicial liquidation has fundamentally altered its ownership. While specific ownership percentages for institutional investors or individual shareholders in the pre-liquidation phase are not detailed, Bpifrance, a public investment bank, was a key stakeholder in 2022, having provided a substantial €73 million capital injection. Benjamin Gonzalez held the positions of Chairman and CEO. As of July 20, 2025, the market capitalization stood at approximately €6.2 million, with trailing twelve-month revenue of $174 million and a net loss of -$51.63 million as of June 30, 2023. The recent judicial liquidation means that METabolic EXplorer shares will have no trading value, and proceeds from asset disposals will not be distributed to shareholders.
METabolic EXplorer Ownership Evolution
The METabolic EXplorer ownership history is marked by significant shifts, culminating in its recent liquidation. Understanding these changes is crucial for comprehending the company's trajectory.
- Public listing on Euronext Paris in 2007.
- Divestment of methionine technology in 2016.
- Initiation of receivership in May 2024.
- Judicial liquidation in July 2024, leading to zero share value.
- The Target Market of METabolic EXplorer was impacted by these structural changes.
METabolic EXplorer PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on METabolic EXplorer’s Board?
As of October 1, 2024, the executive leadership of METabolic EXplorer included Benjamin Gonzalez as Chairman and CEO, Rudolph Hidalgo as Deputy General Manager, Laurent Bastian as CFO, Laurence Caron as Chief Human Resources Officer, and Maria Wiltz as Chief Strategy and Development Officer. The company's ownership structure and voting power have been significantly impacted by recent judicial proceedings.
| Executive Role | Name |
|---|---|
| Chairman and Chief Executive Officer | Benjamin Gonzalez |
| Deputy General Manager | Rudolph Hidalgo |
| Chief Financial Officer | Laurent Bastian |
| Chief Human Resources Officer | Laurence Caron |
| Chief Strategy and Development Officer | Maria Wiltz |
As of March 31, 2024, METabolic EXplorer had 50,919,133 shares outstanding with theoretical voting rights totaling 52,823,299. Shares held in treasury, amounting to 234,556, did not confer exercisable voting rights, leaving 52,589,143 exercisable voting rights. However, the judicial liquidation ordered in July 2024 has fundamentally altered the company's ownership and control dynamics, rendering previous voting power irrelevant.
Impact of Judicial Liquidation on Ownership
The court's decision to move from receivership to judicial liquidation means that METabolic EXplorer's assets will not be distributed to shareholders. Consequently, the company's shares are slated for delisting with no residual value, effectively nullifying any prior shareholder voting power or claims on ownership.
- Judicial liquidation ordered in July 2024.
- Assets will not be returned to shareholders.
- Shares to be delisted with zero value.
- Previous voting power is now void.
Understanding the Competitors Landscape of METabolic EXplorer is crucial, but the current situation means that traditional metrics of METabolic EXplorer ownership and who owns METabolic EXplorer are no longer applicable. The METabolic EXplorer company structure has been dissolved through legal proceedings, and there are no current owners in the conventional sense. The METabolic EXplorer board of directors' authority has ceased with the liquidation order. Information regarding METabolic EXplorer major investors or METabolic EXplorer stock ownership information is now historical, as the company's shares will be delisted without value.
METabolic EXplorer Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped METabolic EXplorer’s Ownership Landscape?
The ownership landscape of METabolic EXplorer underwent a dramatic and final shift in July 2024 with its judicial liquidation. Following receivership proceedings initiated in May 2024, the company's assets and activities were sold, effectively dissolving the previous ownership structure and rendering existing shares worthless.
| Event | Date | Outcome |
|---|---|---|
| Receivership Proceedings Initiated | May 2024 | Company entered receivership. |
| Avril Appointed Buyer | July 12, 2024 | Avril purchased activities of METEX NØØVISTAGO and parts of METabolic EXplorer's commercial and R&D operations. |
| Judicial Liquidation Ordered | July 16, 2024 | Receivership proceedings for both METEX NØØVISTAGO and METabolic EXplorer were converted into judicial liquidation. |
The judicial liquidation signifies the complete cessation of METabolic EXplorer's operations as a going concern. Consequently, trading in METabolic EXplorer shares will not resume, and Euronext is in the process of delisting them. The value of these shares is now effectively zero, with no prospect of payment for shareholders due to the company's substantial liabilities. This outcome represents a total loss of equity for the previous METabolic EXplorer shareholders and a fundamental restructuring of the company's ownership, driven by severe financial distress.
Impact on Shareholders
Shareholders will not receive any compensation following the judicial liquidation. The value of their investment has been entirely extinguished due to the company's liabilities exceeding its assets.
Sectoral Challenges
The company's situation highlights the significant challenges within industrial biotechnology, including high raw material costs and intense international competition, impacting its Growth Strategy of METabolic EXplorer.
Asset Sale to Avril
Avril acquired key activities from METabolic EXplorer and METEX NØØVISTAGO through a court-approved sale. This transaction aimed to preserve certain operational aspects of the business.
Future Ownership Outlook
With the company undergoing judicial liquidation, there are no plans for future ownership changes or succession in the traditional sense. The previous shareholder base has lost all holdings.
METabolic EXplorer Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of METabolic EXplorer Company?
- What is Competitive Landscape of METabolic EXplorer Company?
- What is Growth Strategy and Future Prospects of METabolic EXplorer Company?
- How Does METabolic EXplorer Company Work?
- What is Sales and Marketing Strategy of METabolic EXplorer Company?
- What are Mission Vision & Core Values of METabolic EXplorer Company?
- What is Customer Demographics and Target Market of METabolic EXplorer Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.